<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 127 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page126.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=127">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 127 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 127</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=127"><img src="../thumb/127.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>96 / 2020-04                                                         Cardio-Vascular Agents - 7.3.3
   Contraindications: Uncontr.asthma/card.fail., 2nd & 3rd degr.heart   diab.mellit., anaesth./surg., concom.Class 1 antidysrhythm. agents/   dly for furth. wk., incr.to 3,75 mg once dly. for furth.wk., incr.to 5 mg
   block & bradycard., pregn.& lactat., metabol.acidos., sinus bradycard.  myocard.depress./AV conduct.inhibits., clonidine transf., discont.  once dly for follow.4 wks. Maint.ther: max. 10 mg once dly. Pt.to be
   (less than 50 bpm), phaeochromocyt., hyperthyroid., caut.esp. in asth-  clonidine sev.days aft. Bilocor withdr.if giv.concurr., grad.withdr.,   observ.over approx.4 hrs aft.ther.init.regard.BP/heart rate/conduct.
   ma/ bronchit./chron.resp. distress/periph. vasc. dis./Raynaud’s phe-  phys. activ.limit.dur.withdr.per., pulse rate & response to be monit.in   disturbs./ worsen.HF signs. Dos.reach.may be decr.grad.if necess.
   nom., reduc.dos.in elderly/ ren.dysfunct., poss.ang. pect./hypertens.   CCF pts.if digox.used concom., concom. verapamil in pts.with imp.  Treatm.may be interrupt.& re-introduc.as appropr.
   aggravat. if dos.reduc.dur.peri-op per., norm. tachycard. respons.to   ventric.funct.& to pts. with conduct.abnormalit., concom.IV admin.  Contraindications: Ac.HF/dur.HF episod. decompensat. requir.
   hypovolaem./bld.loss poss. obscur. dur./aft.surg., hypoglycaem.S&S   with Ca antagon.& antiarrythm.not recomm., tachycard. assoc.with   IV inotrop.ther., cardiogen. shock, 2nd & 3rd degr.AV block (with-
   poss. mask./ dimin.respons.in diab.mellit.  hypoglycaem.modif.  out a pacemaker), sick sinus syndr., sinoatr.block, bradycard. (less
   Side effects: Bld.disords., hypoglycaem., hypercholesterolaem., CNS   Drug interactions: Poss.life-threat.vasoconstrict. with alpha adreno-  than 50 bpm) bef.init.ther., hypotens. (syst.BP less than 100 mmHg),
   effs.incl. dizzin., headache, hallucin., psychos., cold extremit., hypo-  cept.stimul./adrenerg.neurone block.agents, ß-adrenocept.stimulat.  bronch. asthma, bronchit., sev.COPD, periph.art.occlus.dis., Raynaud’s
   tens., paradox.hypertens., paraesthes., vis. disturbs., CV effs.incl.CCF/   agents may antagon.effs., concom.hypoglycaem.agents/ phenothiaz./   syndr., phaeochromocyt., metabol. acidos., pregn.& lactat., hyperthy-
   heart block/mark. bradycard./ periph.vasc.dis.exacerbat./Raynaud’s   various anti-arrythm.agents poss.life threaten.  roid., periph.vasc. dis., sin.bradycard., safety & effic.in childr.not est.
   phenom., fluid retent., periph.gangr.poss.precipit., bronchoconstrict. in   Side effects: Bld./psych.disords., hypersens./ allerg./ skin reacts.,
   pts.with chron.pulm.dis., GI/ metabol. disturbs., stomatit., mass gain,   BILOCOR CO, Pharma Dynamics  SLE, metabol./vis.disturbs., hypo-/ hyperglycaem., hypercholesterol-
   rais.liv. enzym., skin/hypersens.reacts., alopec., musc. cramps, myo-  Bisoprolol fumarate 2,5(5; 10)mg, hydrochlorothiazide 6,25(6,25;   aem., incr. uric acid lev., triglycer.bld.conc.chang., CNS effs., dizzin.,
   pathy, skelet.musc.weakn., trans.hear. loss, sex.impot.  6,25)mg   headache, convuls., coma, decr.tear product., conjunctivit., hear.
   Warnings and special precautions: Safety & effic. in childr.not   Indications: Hypertens.  loss/impairm., bradycard., fluid retent,heart block, bronchosp.in pts.
   est., anaesth./surg., sev.ren. impairm., concom.Class 1 antidysrhythm.   (S3) TABS, A44/7.1.3/1010, 1011, 1012  with asthma, psorias.aggrav., CHF, AV stimul. disturbs., HF worsen.,
   agents/ myocard.depress./AV conduct.inhibits., clonidine transf., con-  719200-001:2,5/6,25 mg, 30, R103,56  orthostat.hypotens., cold/ numb extremit., paraesthes., paradox.
   com.verapamil.in pts.with imp.ventric. funct., not to be giv.in conduct.  719201-001: 5/6,25 mg, 30, R109,93  hypertens., periph. vasc.dis.exacerbat./Raynaud’s phenom., periph.
   abnormalit., neith. drug to be giv.IV with.48 hrs.of discont.the other,   719202-001: 10/6,25 mg, 30, R117,89  gangr., bronchosp.in pts.with bronch. asthma/ obstruct.airway dis.
   concom. IV Ca antagon. & antiarrythm.not recomm., tachycard.assoc.  Dosage: Adults: Init. one 2,5/6,25 mg tab.dly. Subseq. dos.adjustm.  hist., shortn.of breath, dyspn., pneum., pulmon.fibros., pleurisy, GI
   with hypoglycaem. modif., alpha-adrenerg.block.treatm.in phaeochro-  as appropr.up to max. recomm. dos.of one 10/6,25 mg dly.  disturbs., stomatit., hepatotoxic., hepatit., perspirat., alopec., psorias.
   mocytoma, ang.pect.exacerbat.in ischaem. heart dis.in case of abrupt   Contraindications: Other sulphonamide deriv. agent hypersens.,   exacerbat., musc. weakn., cramp., myopath., back/joint pain, potency
   ther. discont., grad. withdr., limit.phys.activ.dur.withdr.per., floppy inft.  2nd & 3rd degr.heart block, bradycard. (less than 50 bpm), pregn.&   disords., mass gain, asthen.
   syndr.if admin.shortly bef.birth/ dur.labour.  lactat., cardiogen. shock, uncontr.card.fail., sev.hypotens. (systol. BP   Warnings and special precautions: Elderly, sev. ren.impairm.,
   Interactions: Poss.life-threat.react.with hypoglycaem. agents/  &lt;100mm Hg), metabol.acidos., sinus bradycard., phaeochromocyt.,   peri-op per., tachycard. respons. due to hypovol./bld.loss poss.ob-
   phenothiazin. & var.anti-arrhythm.agents, ß-adrenocept.stimulat.  hyperthyroid., bronchosp., asthma, bronchit./chron.resp.dis.hist.,   scur.dur./aft.surg., concom. inhalat.anaesthet., diab.mellit., strict fast.,
   agents may antagon.effs., life-threat.vasoconstrict.with concom.  late stage periph.vasc.dis., Raynauds, Addisons dis., sev.ren./hepat.  ongo. densensitivit.ther., 1  degr.AV block, Prinzmetal’s ang., periph.
                                                                         st
   alpha-adrenocept.stimul.& adrenerg. neurone block.agents, monit.  impairm., porphyr., safety & effic. in childr.less than 12 yrs.not est.,   arter.occlus.dis., hyperthyroid/ thyrotoxicos.sympt.poss.mask., no
   pt.respons./pulse rate with concom.digox.in CHF pts.  concom.Ca chann.blocks.  exper. in HF treatm.in follow: NYHA class II HF/ insul. depend.diab.
   See also MDR page 54.        Side effects: Bld.dyscras., hyperuricaem., hypo-/hyperglycaem.,   mellit./imp.ren.funct.(ser. creatin. &lt; 80 /min)/ imp.liv.funct./pts.old.
   B-BLOCK , Unicorn Pharmaceuticals (Pty) Ltd  glycosur., hypersens.incl. anaphylact. reacts., pancreatit., sialadenit.,   than 80 yrs./ restrict.cardiomyopathy/congenit.heart dis./ haemo-
                                metabol. disturbs., incr.uric acid lev., hypercholesterolaem., electrol.
   See Section 7.4.2            imbal.incl. hyponatraem., anorex., psych.disords. incl. psychos., CNS   dynamic.signif.organ.valvul.dis./MI with.3 mnths., poss.incr.sens.
                                                              towards allerg./ anaphylact.reacts.sever., reg.monit.esp.init., grad.
   BETACOR, Merck [N/P/S in C in only certain sports]  effs., weakn., drowsin., dizzin., headache, orthostat.hypotens., par-  withdr., physic.activ.to be limit.on withdr., concom. Class-I & Class-
   Bisoprolol fumarate          adox. hypertens., paraesthes., vertigo, fev., restlessn., eye disords.,   III antidysrhythm.agents/ myocard. depress./AV conduct.inhibits.,
   Indications: Mild to mod.hypertens., ang.pect.  vis.disturbs., xanthops., trans.hear. loss, bradycard., CHF, heart block,   clonidine transf., concom. verapamil.in pts.with imp.ventric.funct.&
   (S3) TABS, 38/5.2/0080,0081  dysrhythm., fluid retent., reduc.periph.circulat., periph.vasc.dis. exac-  neith.to be admin.IV with. 48 hrs. of discont.the other, concom.IV Ca
   706178-001: 5 mg, 30, R54,15  erbat./ Raynaud’s phenom./periph.gangrene poss. precipit., necrotis.  antagon.& antidysrhythm. agents not recomm., alpha-adrenerg.block.
   706179-001: 10 mg, 30, R93,66  vasculit., allerg.rhinit., nas. congest., bronchoconstrict.in asthma/   treatm.in phaeochromocytoma, pulse rate/pt. respons. monit.with
   Dosage: Adults: Indiv. 5 -10 mg once dly.in the morn. Max.recomm.  bronchit./ other chron.pulm.dis., resp.distress incl.ac. interstit. pneu-  concom.digoxin in CHF, modif.tachycard.assoc.with hypoglycaem.,
   dos: 20 mg dly.              monit.& pulm.oed., GI disturbs., mass gain, stomatit., hepatotox.,   concom.mefloquine/sympathomimet.agents.
   Contraindications: Uncontroll.asthma, 2nd & 3rd degr.heart block   rais.liv.enzym., jaund., skin reacts., perspirat., alopec., photosens.,   Drug interactions: Hypoglycaem.with oral hypoglycaem agents
   & bradycard., pregn.& lactat., uncontr.card.fail., metabol.acidos., si-  back/joint/ chest pain, musc.cramps/spasm, myopathy, skelet.musc.  & insul., myocard.depress. with antidysrhythm.agents, eff.antagon.
   nus bradycard. (less than 50 bpm), phaeochromocyt., hyperthyroid.,   weakn., ren.dysfunct./fail., interstit. nephrit., impot., reduc.tear flow.  with beta-adrenocept. stimlat.agents,life threat. vasoconstrict. effs.
   safety & effic.in childr.not est., concom. IV Ca antagon.& antiarrythm.  Special precautions: At least 48 hrs.to elapse betw. last dos.&   with alpha-adrenocept.stimul. & adrenerg.neurone block.agents,
   agents not recomm.           surg.if ther.to be withdr.bef. anaesth., concom.ether/cycloprane/   poss. heart rate reduct./ incr.AV conduct.time with digoxin, short.
   Side effects: Bld.disords., CV effs.incl.CCF/heart block/periph.vasc.  trichloroethylene dur.anaesthes., maint.usual dos. peri-op., ren./  half-life with concom.rifampicin, poss.add.syst. S/E with topic.beta-
   dis.exacerbat./Raynaud’s phenom./periph.gangrene poss.precipit.,   hepat.impairm., progress.liv.dis., discont. grad.& monit.pt.caref.,   block.eye drops, incr. bradycard. risk with mefloquine, poss. profound
   CNS effs. incl.hallucin., paradoxic.hypertens., paraesthes., psychos.,   elderly, periph. vasc. dis exacerbat./ Raynaud’s developm., periph.   hypotens. & AV block with verapamil IV, Ca antagon. have negat.eff.
   metabol.disturbs., hypoglycaem., incr. uric acid, hypercholesterolaem.,   gangr. precipit., eye irrit.with cont.lens., clonidine transf., ang.pect.   on contractilit./AV conduct./ BP, incr rebound hypertens.risk & exag-
   GI disturbs., stomatit., rais.liv.enzymes, musc.cramps, myopathy, skel-  exacerbat. in pts.with ischaem. heart dis. when ther.discont.abrupt.,   gerat. heart rate decr./card.conduct.with clonidine/ other central.
   et.musc.weakn., vis.disturbs., skin reacts., alopec., trans.hear.loss,   limit.phys. activ. dur.withdr.per., poss. psorias.exacerbat., antidiab.
   hypersens.reacts., sex.impot., bronchoconstrict.in asthma/bronchit./   agent dos.adjustm.incl.insul., hyperuricaem. &/ gout precipit.in cert.  act.antihypertens., incr.β-block. hypotens.eff./hypertens.crisis risk
                                                              with MAOI, incr.eff.on atr.conduct.time /incr.neg. inotrop. eff.with
   other chron.pulm.dis., poss.ang.pect.exacerbat. with abrupt withdr.,   pts., tachycard. respons.poss.obscur., concom.Class 1 antidysrhythm.
   floppy inft.syndr.if admin.to mothers shortly bef.birth/dur.labour.  agents/myocard.depress./AV conduct. inhibits., concom.verapamil in   Class-I antidysrhythm.meds., eff. on atr. conduct.time poss.potent.
                                                              with Class-III antidysrhythm. meds., AV conduct.time/bradycard. risk.
   Special precautions: Asthma, bronchit., chron. resp.dis., periph.  imp. ventric. funct.& neith.to be admin.IV within 48 hrs. of discont.the
   vasc.dis., Raynaud’s phenom., elderly, sev.ren.dysfunct., periop   other, avoid IV admin.of Ca antagon. & antidysrhythm. agents, alpha-  poss.incr.with parasympathomimet. meds. incl. tacrine, poss.intensif.
                                                              bld.gluc.lower.eff.with anti-diabet.meds., hypoglycaem.sympt.poss.
   per., diab.mellit. as hypoglycaem.S&S.poss.mask./respons.to hy-  adrenerg.block. pre-treatm. usual.reqd.in phaeochromocytoma, diab.
   poglycaem.poss.dimin., at least 48 hrs.to elapse betw.last dos.&   mellit.as hypoglycaem.S&S.poss.mask./ respons. to hypoglycaem.  mask. by block.of β-adrenocept., anaesthet.agents may lead to re-
                                                              flex tachycard.attenuat.& incr.hypotens. risk, hypotens.eff.decr.with
   surg.if ther.to be withdr.bef. anaesth., concom.ether/cycloprane/   poss.dimin., poss.delay. recov. from insul.-induc.hypoglycaem., monit.
   trichloroethylene dur.anaesthes., maint.usual dos. peri-op., tachy-  pulse rate & pt.response in CCF pts.with concom.digox., poss. incr.  prostagland.synthet. inhibits., periph.circulat.disturbs.exacerbat.with
   card.respons.poss.obscur., concom. Class 1 antidysrhythm. agents/  sensitiv.towards allerg.& anaphylact. reacts. with adrenal.not always   ergot derivats., reduc.eff.of both agents with concom. combinat.of
   myocard.depress./ AV conduct.inhibits., clonidine transf., concom.   have expect.eff., decr. urin.Ca excret.may result in intermit.slight. rais.   sympathomimets., poss.incr. BP low.eff.with TCA’s/ barbits./pheno-
   verapamil in imp.ventric.funct.& neith.to be admin. IV within 48 hrs.  ser.Ca but mark.hypercalcaem.poss.evid.of underly. hyperparathyroid.,   thiazin./ other antihypertens.agents.
   of discont.the other, tachycard. assoc.with hypoglycaem.modif.,   potent.life-threat. react. with concom. quinidine, hydrochlorothiazide   BISLO, (Activo) Unichem [N/P/S in C in only cert.sports]
   alpha-adrenerg. block.treatm.usual.reqd.in phaeochromocytoma,   cross. placenta & excret.in breast milk, SLE, gluc. tol. impairm., decr.  Bisoprolol fumarate
   monit.pulse rate & pt.response in CCF pts.with concom.digox., ad-  urin.Ca excret., incr.triglyceride/ cholest. lev., sens.reacts.with/with-  Indications: Mild to mod.hypertens., ang.pect.
   verse reacts.more common in ren. decompensat., grad.withdr., limit.  out allergy hist./ bronch.asthma,  (S3) TABS, 45/5.2/0128, 0129
   phys.activ. dur.withdr.per.  Drug interactions: Half-life short.by strong hepat. cytochrome   719154-001: 5 mg, 30, R54,00
   Drug interactions: Concom.hypoglycaem. agents/ phenothiaz./  P450 isoenzymes induc.(CYP 3A4 & 2D6), half-life incr.by strong   719155-001: 10 mg, 30, R90,91
   various anti-dysrhythm. agents poss.life threaten., ß-adrenocept.   hepat. cytochrome P450 isoenzymes inhibit.(CYP 3A4 & 2D6), eff.   Dosage: Adults: Indiv.accord.to toler./respons. 5 -10 mg once dly.in
   stimulat.agents may antagon.effs., poss.life-threat. vasoconstrict.   of other antihypertens.potent., HF poss. worsen. with centr.act.  the morn. Max.dly.recomm.dos: 20 mg.
   with alpha adrenocept.stimul./ adrenerg.neurone block.agents.  antihypertens., add.syst.S/E with topic.B-block. eye drops, concom.   Contraindications: 2nd & 3rd degr.heart block & bradycard.,
   BILOCOR, Pharma Dynamics [PWR]  hypoglycaem. agents/phenothiaz./various anti-dysrhythm. agents   pregn.& lactat., uncontr.CF, hypotens., metabol.acidos., sinus
                                poss.life threaten., ß-adrenocept.stimulat. agents may antagon.
   Bisoprolol fumarate                                        bradycard.(less than 50 bpm), hyperthyroid., asthma, bronchosp.,
   Indications: Mild to moder.hypertens., ang.pect.  effs., poss.life-threat. vasoconstrict. with alpha adrenocept.stimul./   bronchit./ chron.resp.dis., late stage periph.vasc. dis., Raynaud’s
   (S3) TABS, 38/5.2/0053, 0051  adrenerg.neurone block.agents, responsiven.to competit.neuro-  phenom., safety & effic.in childr. not est., concom.IV Ca antagon.&
   704372-001: 5 mg, 30, R54,00  musc.block.incr., orthostat.hypotens. potent. by alcoh./barbitur.&   antidysrhythm. agents not recomm., concom.Ca chann.blocks
   704373-001: 10 mg, 30, R93,30  narcot., concom. corticoster./ ACTH intensify electrol.deplet & hy-  e.g.diltiazem/ verapamil.
   Dosage: Adults: Indiv.5 -10 mg once dly in the morn. Max.dly.  pokalaem., decr.respons.to press.amines but not suffic. to preclude   Side effects: Bld.disords., hypersens./allerg. reacts., hypoglycaem.,
   recomm.dos: 20 mg.           their use, NSAID reduc. antihypertens. effs., sev.hyponatraem.with   hypercholesterolaem., metab./GI disturbs., incr.uric acid lev., psych.
   Contraindications: Uncontroll.asthma, 2nd & 3rd degr.heart block   trimethoprim / carbamazepine.  disords. incl.psychos., dizzin., paraesthes., CNS effs.incl.drowsin.,
   & bradycard., pregn.& lactat., uncontr.card.fail., metabol.acidos., si-  BIO ATENOLOL, Biotech Laboratories (Pty) Ltd  weakn., headache, vis.disturbs., reduc.tear flow, hear.loss, mass
   nus bradycard.(less than 50 bpm), phaeochromocyt., hyperthyroid.,   See Section 7.4.2  gain, stomatit., bradycard., CHF, dysrhythm., heart block, fluid retent.,
   safety & effic.in childr.not est.                          orthostat.hypotens., reduc.periph.circulat., paradox.hypertens., pe-
   Side effects: Bld.disords., CV effs.incl.CCF/ heart block/periph.vasc.  BISBETA, Aurobindo [PWR]  riph.vasc.dis.exacerbat./ Raynaud’s phenom., periph.gangr.precipit.,
   dis.exacerbat./Raynaud’s phenom, periph.gangrene, paradoxic.hyper-  Bisoprolol fumarate  bronchosp./ bronchoconstrict.in asthma/bronchit./ chron. pulm.dis.
   tens., CNS eff., paraesthes., metabol.disturbs., hypoglycaem., hyper-  Indications: Stable chron.mod.to sev.HF with reduc.syst.ventric.dys-  pts., allerg.rhinit., nas.congest., hepatotoxic., rais.liv.enzym., choles-
   cholesterolaem., GI disturbs., stomatit., mass gain, hepatotox., musc.  funct.in addit.to ACE inhibits./diurets./option.digox.prior to ther.init.  tat.jaund., skin reacts.incl.psorias.if.erupt., alopec., back-/joint-/ chest
   cramps, myopathy, skelet.musc.weakn., vis.disturbs., skin reacts.,   (S3) TABS. 45/5.2/0790, 0791  pain, musc.cramps, myopathy, skelet.musc. weakn., impot., insul.in-
   trans.hear.loss, hypersens.reacts., sex. impot., resp.disords., floppy   720659-001: 5 mg, 30, R53,97  duc.hypoglycaem.recov. delay.
   inft.syndr.if admin. shortly bef.birth/dur.labour.  720660-001: 10 mg, 30, R93,27  Special precautions: Diab.mellit.as hypoglycaem. S&S poss.
   Special precautions: Asthma, bronchit., chron. resp.dis., periph.  Dosage: Admin.in the morn. Swall.tabs.without chew. Init.with grad.  mask./respons.to hypoglycaem. poss.dimin., elderly, ren.dysfunct.,
   vasc.dis., Raynaud’s phenom., elderly, ren.dysfunct., periop peroid,   uptitrat.if well toler: 1,25 mg once dly.for 1 wk incr.to 2,5 mg once   concom.Class 1 antidysrhythm.agents/myocard. depress./AV con-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page126.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>&nbsp;&nbsp;&nbsp;<a href="page128.html">128</a>&nbsp;&nbsp;&nbsp;<a href="page129.html">129</a>&nbsp;&nbsp;&nbsp;<a href="page130.html">130</a>&nbsp;&nbsp;&nbsp;<a href="page131.html">131</a>&nbsp;&nbsp;&nbsp;<a href="page132.html">132</a>
             </td>
             <td width="35%"><a href="page128.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page128.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
